# Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment

> **NCT00122356** · PHASE3 · COMPLETED · sponsor: **Barwon Health** · enrollment: 303 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Alendronate sodium

## Key facts

- **NCT ID:** NCT00122356
- **Lead sponsor:** Barwon Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2013-02
- **Final completion:** 2013-03
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2013-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00122356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00122356, "Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00122356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*